Host DCs then activate donor T cells in the graft, which migrate to GVHD target organs and release pro-inflammatory cytokines, including interferon (IFN)-γ [27] and interleukin (IL)-17 which drive inflammatory damage [28]. Here, IFNG is linked to graft versus host disease.